Zolinza for Hodgkin’s
Current chemotherapy drugs are very effective for Hodgkin's lymphomas but patients who relapse after receiving them don;t do as well. This is because the cancers develop resistance to the se drugs. Zolinza is a new drug approved in the USA for the treatment of cutaneous(skin) T-cell lymphoma who have progressive, persistent or recurrent disease or following two systemic therapies. It may be effective for Hodgkin's. For Hodgkin's, a phase
Read more